Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Related Posts Hempalta Provides Strategic Update Regarding Equipment Sale and FCC Agreement June 7, 2025 Ford Government Pushes Bill 5 Through Legislature, Sparking First Nations Outcry June 7, 2025 Top 5 Canadian Mining Stocks This Week: Africa Energy Jumps 275 Percent June 7, 2025